2026-03-30 M2 macrophages predict response to neoadjuvant chemotherapy in triple negative breast cancer patients
2026-03-30 Elucidating the relationship between affinity and potency in the performance of therapeutic IgE
2026-03-24 TRIM21-mediated degradation of HILPDA overcomes anti-PD-1 immunotherapy resistance in breast cancer by limiting PD-L1 palmitoylation
2026-03-20 The DAG/PKC/CREB1/TGF-β1 axis drives shear-wave elastography stiffness and malignant progression in triple-negative breast cancer via lipid metabolic reprogramming
2026-03-11 Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors
2026-03-05 Molecular insights into Silodosin’s anti-cancer effects: a promising repurposing strategy for breast cancer
2026-03-02 Shp1 phosphatase regulates CXCR2 protein stability and IL8-mediated invasiveness in breast cancer
2026-03-02 A Lamp2a-linked RNA secreted by ADSCs prevents ENO1–lactylation–glycolysis feedback and cell malignant behavior in triple-negative breast cancer
2026-02-28 GTPBP2 inactivates Hippo signaling to promote triple-negative breast cancer cell malignancy
2026-02-25 Deubiquitinase UCH-L1 confers paclitaxel resistance via stabilizing PKM2 to promote glycolysis in triple-negative breast cancer
2026-02-25 M2 macrophages promote lymphatic metastasis by regulating PKM2 nuclear translocation in triple-negative breast cancer
2026-02-24 Transcriptomic analysis to uncover the mechanism of radiosensitization of AR-positive triple-negative breast cancers with AR inhibition
2026-02-23 OTUD4 deubiquitination stabilizes EGFR and activates the PI3K/AKT pathway to promote the invasiveness of triple-negative breast cancer
2026-02-21 EGFR and AR expression and co-expression in Indian triple-negative breast cancer with patient outcome association
2026-02-16 Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies
2026-02-13 Preliminary exploration of radiomic mammographic analysis in triple negative breast cancer related to BRCA profile
2026-02-13 Programmable local immunochemotherapy for triple-negative breast cancer via spatiotemporally controlled release of CpG oligodeoxynucleotides, gemcitabine, and paclitaxel
2026-02-11 CD36 enhances sensitivity of triple negative breast cancer cells to palmitate-induced ferroptosis
2026-02-07 Constitutional BRCA1 Methylation is associated with high level of tumoral BRCA1 methylation and homologous recombination deficiency in triple-negative breast cancer
2026-02-06 Extracellular matrix mediates circulating tumor cell clustering in triple-negative breast cancer metastasis
2026-02-05 Real-world use and survival outcomes of sacituzumab govitecan in metastatic triple-negative breast cancer and hormone receptor-positive/HER2-negative metastatic breast cancer
2026-02-03 Safety and preliminary efficacy of adding tocilizumab to cisplatin/docetaxel for the treatment of locally advanced triple-negative breast cancer patients: prospective phase 1/2 clinical trial
2026-02-01 Integrating network toxicology, machine learning, and molecular dynamics simulations to reveal tanshinone iia’s dual mechanisms in TNBC and doxorubicin-induced cardiotoxicity
2026-01-31 Radiosensitizing effects of silver nanoparticles targeting angiogenesis and matrix metalloproteinase signaling in triple negative breast cancer cell lines
2026-01-31 Ononin suppresses tumor-induced platelet activation and invasion and enhances cell-cycle arrest and apoptosis in triple-negative breast cancer cells
2026-01-30 The CXCL10/CXCR3 axis is essential for sustaining immunological dormancy in triple-negative breast cancer
2026-01-26 Co-delivery of chemokine CXCL9 and costimulatory ligand TNFSF9 by mesenchymal stem cells reprograms the immune microenvironment for triple-negative breast cancer
2026-01-24 CD52 signaling via macrophage Siglec-G represents a therapeutic target for cancer immunotherapy
2026-01-20 From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer
2026-01-19 Algorithm-assisted individualized therapy design improves survival in a mouse model of triple-negative breast cancer
2026-01-17 Low tumoral Trefoil Factor 1 expression relates to aggressive tumor features and poor survival in young women with breast cancer
2026-01-14 Integrated proteomics and metabolomics reveal phytosesquiterpene lactones inhibit TNBC cell activity by depleting ATP synthesis and reprogramming primary metabolism